EMCDDA Home
  • EN
Search

Figure INF-6. HCV antibody prevalence among injecting drug users: studies with national and sub-national coverage.

Part (i) All injecting drug users, 2010–11

 
 
CountryyearNationalSub-national
Related links:
Czech Republic201118.2
Hungary201124.123.89.934.231.2
Slovenia201128.5
Malta201134.4
Slovakia201140.3
Austria201148.534.269.667.138.6
United Kingdom^ 201143.044.528.753.2
Turkey201148.6
Cyprus201152.6
Sweden201055.7
Portugal***2010/201179.736.5
Netherlands^^2010/201150.067.4
Italy*201060.567.558.943.534.565.146.363.455.579.856.965.161.969.164.568.580.5
Latvia**2010/201181.558.952.450.0
Belgium201181.542.3
Germany201156.071.6
Norway201165.063.3
Greece201169.462.479.376.567.561.735.067.471.752.636.43359.6706160.5
Bulgaria201167.8
Estonia201076.0
Poland
Finland
Romania
Denmark
Croatia
Luxembourg
Lithuania
France
Ireland
Spain
http://www.emcdda.europa.eu/stats13/inffig6a
For primary sources, study details and data before 2010, see INF-111 and INF-0
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Black squares are samples with national coverage; blue triangles are samples with sub-national (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

Sources:

Reitox Network

CountryCzech RepublicHungarySloveniaMaltaSlovakiaAustriaUnited Kingdom^TurkeyCyprusSwedenPortugal***Netherlands^^Italy*Latvia**BelgiumGermanyNorwayGreeceBulgariaEstonia
National18.224.128.534.4 48.543.048.652.6 79.7 60.5   65.069.4  
National     34.2    36.5      62.4  
                     
Subnational 23.8  40.369.644.5  55.7 50.067.581.581.556.063.379.367.876.0
Subnational 9.9   67.128.7    67.458.958.942.371.6 76.5  
 Subnational 34.2   38.653.2     43.552.4   67.5  
 Subnational 31.2          34.550.0   61.7  
 Subnational            65.1    35.0  
 Subnational            46.3    67.4  
 Subnational            63.4    71.7  
 Subnational            55.5    52.6  
 Subnational            79.8    36.4  
 Subnational            56.9    33.3  
 Subnational            65.1    59.6  
 Subnational            61.9    70.3  
 Subnational            69.1    60.6  
 Subnational            64.5    60.5  
 Subnational            68.5       
 Subnational            80.5       

 

inffig6a

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 27 November 2013